Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.
Bio & Medicine
May 16, 2013
2
1
Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
Biochemistry
Apr 21, 2013
0
0
(Phys.org)—The medical community is armed with new insights and new options for drug design and discovery to treat fatal diseases such as pancreatic cancer. Using in silico computational tools to complement the results ...
Bio & Medicine
Oct 10, 2012
0
0
(Phys.org) -- With the aid of a novel set of lipid-coated, targeted quantum dots, researchers at Johns Hopkins University have developed a method for quantifying multiple specific biomarkers on the surfaces of individual ...
Bio & Medicine
Apr 6, 2012
0
0
The Wall Street Journal is reporting that the funeral for Apple co-founder Steve Jobs is being held Friday.
Other
Oct 8, 2011
0
0
(AP) -- Steve Jobs managed to live more than seven years with a rare form of pancreatic cancer that grows more slowly than the common kind. But his need for a liver transplant two years ago was a bad sign that his troubles ...
Business
Oct 6, 2011
8
0
(PhysOrg.com) -- Researchers at The University of Texas at Arlington are perfecting a system to detect a gene mutation implicated in 90 percent of pancreatic cancers and often in lung cancer by running tiny amounts of blood ...
Bio & Medicine
Mar 11, 2011
0
0
A five-year, $16-million grant from the National Cancer Institute will take advantage of specialized expertise developed by scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore, the University ...
Bio & Medicine
Jan 3, 2011
0
0
One of the most frustrating problems faced by doctors who treat pancreatic cancer is the lack of effective therapeutic options. More than 38,000 people in the United States die of the disease each year, and new drugs and ...
Biochemistry
Nov 5, 2010
0
0
By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...
Bio & Medicine
Oct 28, 2010
0
0
